Across TCGA pan-cancer cohorts, KDM5C mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated KDM5C data layer compared with 25 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KDM5C mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated KDM5C expression acts as an unfavorable survival marker, although some lineages such as UCEC and LSCC show a favorable association.
UCEC, PDAC, and LSCC are the cancer types where KDM5C mass-spec protein most reproducibly stratifies survival.